Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma

The goal of this pilot study is to evaluate the impact of All4Cure enrollment on patients with relapsed multiple myeloma. The main question it aims to answer are:• Does All4Cure effect patient activation as assessed by the PAM-13 survey?Participants will be asked to:fill out quarterly PAM-13 surveys through the All4Cure website to assess patient activation.fill out monthly Patient Reported Outcome (PRO) surveys through the All4Cure website.fill out a baseline and exit All4Cure surveys through the All4Cure website to assess patient perceptions of All4Cure at the beginning and the end of the study.

Inclusion Criteria:have a diagnosis of multiple myeloma that has relapsed one or more times.are aged 18 years and older.can read and e-consent to participate in the study.can speak English.can complete surveys at pre-specified intervals.have access to a device that would allow for the completion of surveys (including at home, at work, at the oncologist's office or elsewhere).are cared for by a physician who is enrolled in All4Cure.Exclusion Criteria:1. Patients will be excluded who are unable to engage with All4Cure or are already participants in All4Cure.